DraftKings Inc. (NASDAQ:DKNG) is one of the best growth stocks to buy for the next 20 years. On February 17, Needham lowered its price target on DraftKings to $35 from $52 with a Buy rating following a Q4 2025 earnings miss and a reduced revenue outlook for fiscal year 2026. While the firm expects the upcoming investor day to be beneficial, the analyst argued that the company must develop a prediction market product on par with Kalshi to drive meaningful revenue and cash flow. Northland analyst Greg Giba ...

Fair Isaac Corporation (NYSE:FICO) is one of the best growth stocks to buy for the next 20 years. On February 17, Bank of America analyst Curtis Nagle reinstated coverage of FICO with a Buy rating and a $1,900 price target, highlighting the company’s strong pricing power and the growth potential of its Mortgage Direct Licensing program. This move was part of a broader reinstatement of 19 stocks within the Information and Business Services sector, for which the firm holds a generally constructive outlook. ...

Arista Networks Inc. (NYSE:ANET) is one of the best growth stocks to buy for the next 20 years. On February 13, Morgan Stanley analyst Meta Marshall raised the firm’s price target on Arista Networks to $165 from $159 and maintained an Overweight rating. This sentiment was posted following the company’s significant Q4 2025 earnings beat. The firm highlighted a $700 million increase in deferred revenue and noted that Arista held its gross margin guidance steady despite headwinds in the memory market. Addit ...

Lam Research Corporation (NASDAQ:LRCX) is one of the best growth stocks to buy for the next 20 years. Earlier on January 29, TD Cowen raised its price target on Lam Research to $290 from $170 while keeping a Buy rating. The firm identified the 2026 Wafer Fabrication Equipment/WFE outlook of $135 billion as a major positive surprise, particularly when considering the current constraints in cleanroom availability. On the same day, RBC Capital raised its price target on Lam Research to $290 from $260 and ma ...

Management pointed to the growth contribution of zero-sugar energy as evidence of a structural change. Fieldly said 85% of energy growth is now coming from zero-sugar products, representing roughly $2.7 billion in incremental category growth, and that Celsius Holdings is “driving the largest share of zero sugar energy growth,” accounting for 33% of category growth.Fieldly framed the energy drink category as increasingly lifestyle-driven, with “zero sugar, functional benefits, and wellness alignment” describ ...

For the full year, Castle said net income was $106.8 million and core income was $103.7 million, an increase of $26.8 million. The company’s combined ratio was 58.6% for the quarter and 60.1% for the full year. American Coastal’s non-GAAP underlying combined ratio—excluding current-year catastrophe losses and prior-year development—was 58.9% for the quarter, down 7 points from the prior year, and 61.5% for the full year, which management said was below its 65% target.CFO Svetlana Castle reported fourth-quar ...

McKenzie said 2025 upstream production averaged 834,000 barrels of oil equivalent per day (BOE/d), the highest annual level in the company’s history and up 3% from 2024 excluding the impact of the MEG acquisition. Cenovus also reduced total upstream non-fuel operating costs by about 4% year over year. In the downstream, the company’s refineries averaged 95% combined utilization across Canadian and U.S. segments, including a 59-day turnaround at Toledo that was completed 11 days ahead of schedule. Cenovus re ...

CRH also pointed to strong cash performance, generating $5.0 billion of adjusted free cash flow , up 18% year-over-year. Buese said this represented 130% conversion of net income and aligned with the company’s longer-term cash conversion targets.Adjusted EBITDA totaled $7.7 billion , an 11% year-over-year increase, alongside 100 basis points of margin expansion . Diluted earnings per share rose 3% versus 2024, or 8% when excluding one-off gains on prior-year divestitures, according to the company.Should You ...

Swanson said Roche’s phase 3 decision was informed by results from two phase 2 trials, PADOVA and PASADENA , and open-label extension data. He highlighted an exploratory endpoint from PADOVA presented by Roche at ADPD 2025: in a subset of participants (about 75% of the PADOVA population) who were on stable levodopa, prasinezumab showed a 40% relative reduction in progression on MDS-UPDRS part 3 versus placebo at 24 months, with a nominal p-value of 0.0177 . He said aspects of the phase 3 design were optimiz ...

You can find original article here Nrn. Subscribe to our free daily Nrn newsletters. Texas Roadhouse celebrated its 33rd anniversary during its fourth quarter earnings call after market Thursday, in which chief executive officer Jerry Morgan led his colleagues in an enthusiastic “yee haw” cheer.  No question the casual-dining chain has much to celebrate, generating nearly $5.8 billion in revenue in 2025 and another year of positive sales and traffic growth. Executives noted that the fourth quarter ...